Bank of America’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-308,660
| Closed | -$3.08M | – | 8515 |
|
|
2025
Q2 | $3.08M | Buy |
308,660
+128,556
| +71% | +$1.04M | ﹤0.01% | 4366 |
|
|
2025
Q1 | $1.08M | Buy |
180,104
+118,773
| +194% | +$872K | ﹤0.01% | 5162 |
|
|
2024
Q4 | $471K | Sell |
61,331
-15,435
| -20% | -$133K | ﹤0.01% | 5583 |
|
|
2024
Q3 | $784K | Sell |
76,766
-7,270
| -9% | -$111K | ﹤0.01% | 5216 |
|
|
2024
Q2 | $1.25M | Buy |
84,036
+28,289
| +51% | +$405K | ﹤0.01% | 4762 |
|
|
2024
Q1 | $760K | Sell |
55,747
-8,931
| -14% | -$97.3K | ﹤0.01% | 5107 |
|
|
2023
Q4 | $708K | Sell |
64,678
-38,797
| -37% | -$385K | ﹤0.01% | 5255 |
|
|
2023
Q3 | $1.13M | Sell |
103,475
-12,389
| -11% | -$158K | ﹤0.01% | 4730 |
|
|
2023
Q2 | $1.53M | Sell |
115,864
-41,766
| -26% | -$596K | ﹤0.01% | 4443 |
|
|
2023
Q1 | $2.15M | Sell |
157,630
-314,885
| -67% | -$5.64M | ﹤0.01% | 4291 |
|
|
2022
Q4 | $9.23M | Buy |
472,515
+126,495
| +37% | +$2.47M | ﹤0.01% | 2767 |
|
|
2022
Q3 | $6.59M | Buy |
346,020
+195,774
| +130% | +$4.51M | ﹤0.01% | 3047 |
|
|
2022
Q2 | $3.1M | Buy |
150,246
+10,667
| +8% | +$253K | ﹤0.01% | 3895 |
|
|
2022
Q1 | $4.49M | Buy |
139,579
+50,521
| +57% | +$1.84M | ﹤0.01% | 3739 |
|
|
2021
Q4 | $4.15M | Buy |
89,058
+66,694
| +298% | +$2.22M | ﹤0.01% | 3839 |
|
|
2021
Q3 | $604K | Buy |
22,364
+14,448
| +183% | +$378K | ﹤0.01% | 5497 |
|
|
2021
Q2 | $203K | Buy |
7,916
+1,753
| +28% | +$41.8K | ﹤0.01% | 6091 |
|
|
2021
Q1 | $211K | Buy |
6,163
+4,509
| +273% | +$163K | ﹤0.01% | 5993 |
|
|
2020
Q4 | $56K | Sell |
1,654
-372
| -18% | -$9.85K | ﹤0.01% | 6279 |
|
|
2020
Q3 | $50K | Buy |
+2,026
| New | +$54.5K | ﹤0.01% | 6017 |
|
Other funds holding ITOS
Bank of America's ITOS Position: Q3 2025 in Review
Bank of America sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 308,660 shares — an estimated $3.08M sold.
Bank of America first reported a position in ITOS in Q3 2020 and held it in 20 quarters. The position peaked at $9.23M in Q4 2022. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.
- Bank of America reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
- Bank of America sold 308,660 iTeos Therapeutics shares in Q3 2025, an estimated $3.08M.
- Bank of America first reported a position in iTeos Therapeutics in Q3 2020 and held it in 20 quarters.
- Bank of America's iTeos Therapeutics position peaked at $9.23M in Q4 2022.
- 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.
Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.